0 Item(s)
Recorded Webinar - Idiopathic Normal Pressure Hydrocephalus: Overview and Neuropsychological Outcomes
Non Member ($50.00) NAN Member ($30.00)
Buy Now
Presented by:
Jeff Schaffert, Ph.D.
Neuropsychologist and Assistant Professor of Psychiatry
UT Southwestern Medical Center
Credit
CE:1.5

Description
Idiopathic normal pressure hydrocephalus (iNPH) is an often unrecognized but relatively common and treatable form of dementia. This presentation will present an overview of iNPH including the prevalence, symptoms, diagnostic considerations, neurocognitive features, and treatment. This presentation will also discuss the pertinent literature and gaps in knowledge regarding short and long-term neurocognitive outcomes.
Learning Objectives
At the end of this presentation, learners will be able to:
1. Describe the clinical presentation, prevalence, and core symptoms of iNPH.
At the end of this presentation, learners will be able to:
1. Describe the clinical presentation, prevalence, and core symptoms of iNPH.
2. Identify key diagnostic considerations and neurocognitive features associated with iNPH.
3. Summarize current treatment approaches for iNPH and their impact on cognitive and functional outcomes.
4. Evaluate the existing literature and recognize gaps in knowledge related to short- and long-term neurocognitive outcomes in iNPH.
Instruction Level: Intermediate
Target Audience: Neuropsychologists, trainees, neurologists, physical therapists
Target Audience: Neuropsychologists, trainees, neurologists, physical therapists
Dr. Jeff Schaffert is a neuropsychologist and Assistant Professor of Psychiatry at UT Southwestern Medical Center. He specializes in the assessment of dementia syndromes, and has research interests in dementia after TBI and normal pressure hydrocephalus. Clinically, he is the primary neuropsychologist within the interdisciplinary NPH clinic and assists the treatment team with neurosurgical decision making and differential diagnosis of NPH. He recently received funding from the Hydrocephalus Association to determine if certain neurocognitive presentations of NPH, combined with imaging and biomarker profiles, predict good shunting response.